Clinical characteristics of of thyroid cancer patients with type 2 DM who exhibited postoperative progression-free survival or progressive disease.

<p>Tg*: Serum thyroglobulin levels 4 to 6 weeks after thyroidectomy in papillary, follicular and Hűrthle cell thyroid cancers. OHÂ: Treatment with an oral hypoglycemia agent, including 9 cases of combination treatment with insulin.</p

Clinical characteristics of thyroid cancer patients with and without type 2 DM.

<p>Tg*: Serum thyroglobulin levels 4 to 6 weeks after thyroidectomy in papillary, follicular, and Hűrthle cell thyroid cancers. Recurrence^#: Percent recurrence1 year after the first thyroid operation.</p

Multivariate analysis of different parameters related to the mortality of thyroid cancer patients with and without type 2 DM using Cox proportional hazard model.

<p>Tg*: Serum thyroglobulin levels 4 to 6 weeks after thyroidectomy in papillary, follicular and Hűrthle cell thyroid cancer.</p

Age distribution of the subjects.

<p>Age distribution and number of thyroid cancer patients were demonstrated with and without type 2 diabetes mellitus (DM). The percentages of type 2 DM were presented in each age group.</p

Cancer-specific and postoperative non-progressive survival curves.

<p>Cancer-specific survival curves for patients with type 2 diabetes mellitus (DM), patients without DM (non-DM), and all patients (A). Postoperative non-progressive survival rates for patients with type 2 DM, patients without DM (non-DM), and all patients (B).</p

Clinical characteristics of survival and mortality groups of thyroid cancer patients with type 2 DM.

<p>Tg*: Serum thyroglobulin levels 4 to 6 weeks after thyroidectomy in papillary, follicular and Hűrthle cell thyroid cancers. OHÂ: Treatment with an oral hypoglycemia agent, including 9 cases of combination treatment with insulin.</p